drugset / Trial / NCT00440102
Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity
RandomizedParallel-groupSingle-blindTreatment
Summary
The expected benefit is a reduction of the morbidity of patients admitted in the intensive care unit having received ketamine for intubation.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-03
- Completion
- 2008-03
Publications
- Results Jabre P, Combes X, Lapostolle F, Dhaouadi M, Ricard-Hibon A, Vivien B, Bertrand L, Beltramini A, Gamand P, Albizzati S, Perdrizet D, Lebail G, Chollet-Xemard C, Maxime V, Brun-Buisson C, Lefrant JY, Bollaert PE, Megarbane B, Ricard JD, Anguel N, Vicaut E, Adnet F; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009 Jul 25;374(9686):293-300. doi: 10.1016/S0140-6736(09)60949-1. Epub 2009 Jul 1.
- Results Wenzel V, Lindner KH. Best pharmacological practice in prehospital intubation. Lancet. 2009 Jul 25;374(9686):267-8. doi: 10.1016/S0140-6736(09)61071-0. Epub 2009 Jul 1. No abstract available.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Etomidate | Small molecule | 0.3 mg/kg | — |
| Comparator | Ketamine | Small molecule | 2 mg/kg | — |
Indications
No indication recorded.